MICHAEL WASSEL: Open Payments
NPI 1356338479 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,725 in 98 payments from 14 companies in 2025. Trend: 2023 $1,250 · 2024 $1,083 · 2025 $1,725
Food & beverage: $1,535Education: $191
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $341 |
| Janssen Biotech, Inc. | 20 | $322 |
| GENZYME CORPORATION | 9 | $212 |
| Regeneron Healthcare Solutions, Inc. | 5 | $211 |
| Galderma Laboratories, L.P. | 15 | $183 |
| UCB, Inc. | 6 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Organon LLC | 4 | $67 |
| Amgen Inc. | 4 | $66 |
| Lilly USA, LLC | 2 | $49 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, Bimzelx, OTEZLA, TALTZ, VTAMA.
Industry payments across PA — which companies pay providers there.
